| Application no. and date | 15720986.7 (espacenet) (Federated) (European Patent Register), 20150505 | | Patent/reg. no. and date | DK/EP 3140320, 20181226 | | Publication date | 20170315 | | Priority no. and date | EP 14167265, 20140506 | | EP pub. no. and date |
EP 3140320 20170315 | | Effective date | | | Applicant/owner | TARGOVAX ASA, Lilleakerveien 2 C
0283 Oslo, NO | | Applicant ref. no. | V149004DK | | Inventor | GAUDERNACK, Gustav, Oslo University Hospital
Radiumhospitalet
Institute for Cancer Research
Dept. of Immunology
Montebello
N-0310 Oslo, NO,
ERIKSEN, Jon Amund, Targovax ASA
Lilleakerveien 2 C
N-0283 Oslo, NO | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 35/17 (2015.01) , A61K 39/00 (2006.01) , A61K 45/06 (2006.01) , C07K 14/82 (2006.01) | | Title | PEPTIDVACCINE, DER OMFATTER MUTANT RAS-PEPTID OG KEMOTERAPEUTISK MIDDEL | | Int. application no. | EP2015059861 | | Int. publication no. | WO2015169804 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
